Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment
- PMID: 26590911
- PMCID: PMC4851715
- DOI: 10.1093/gerona/glv206
Recent Developments in Understanding Brain Aging: Implications for Alzheimer's Disease and Vascular Cognitive Impairment
Abstract
As the population of the Western world is aging, there is increasing awareness of age-related impairments in cognitive function and a rising interest in finding novel approaches to preserve cerebral health. A special collection of articles in The Journals of Gerontology: Biological Sciences and Medical Sciences brings together information of different aspects of brain aging, from latest developments in the field of neurodegenerative disorders to cerebral microvascular mechanisms of cognitive decline. It is emphasized that although the cellular changes that occur within aging neurons have been widely studied, more research is required as new signaling pathways are discovered that can potentially protect cells. New avenues for research targeting cellular senescence, epigenetics, and endocrine mechanisms of brain aging are also discussed. Based on the current literature it is clear that understanding brain aging and reducing risk for neurological disease with age requires searching for mechanisms and treatment options beyond the age-related changes in neuronal function. Thus, comprehensive approaches need to be developed that address the multiple, interrelated mechanisms of brain aging. Attention is brought to the importance of maintenance of cerebromicrovascular health, restoring neuroendocrine balance, and the pressing need for funding more innovative research into the interactions of neuronal, neuroendocrine, inflammatory and microvascular mechanisms of cognitive impairment, and Alzheimer's disease.
Keywords: Alzheimer’s disease; Brain aging; Cerebrovasculature..
© The Author 2015. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Non-pharmacological interventions and neuroplasticity in early stage Alzheimer's disease.Expert Rev Neurother. 2013 Nov;13(11):1235-45. doi: 10.1586/14737175.2013.845086. Epub 2013 Oct 17. Expert Rev Neurother. 2013. PMID: 24134650 Review.
-
SIRT1 as a therapeutic target for Alzheimer's disease.Rev Neurosci. 2016 Dec 1;27(8):813-825. doi: 10.1515/revneuro-2016-0023. Rev Neurosci. 2016. PMID: 27497424 Review.
-
Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.Exp Gerontol. 2017 Aug;94:52-58. doi: 10.1016/j.exger.2016.11.004. Epub 2016 Nov 12. Exp Gerontol. 2017. PMID: 27845201 Free PMC article. Review.
-
Aging, Senescence, and Dementia.J Prev Alzheimers Dis. 2022;9(3):523-531. doi: 10.14283/jpad.2022.42. J Prev Alzheimers Dis. 2022. PMID: 35841253 Review.
-
The role of insulin in the vascular contributions to age-related dementia.Biochim Biophys Acta. 2016 May;1862(5):983-91. doi: 10.1016/j.bbadis.2015.11.013. Epub 2015 Dec 2. Biochim Biophys Acta. 2016. PMID: 26657615 Review.
Cited by
-
Age- and sex-dependent changes in levels of circulating brain-enriched microRNAs during normal aging.Aging (Albany NY). 2018 Oct 31;10(10):3017-3041. doi: 10.18632/aging.101613. Aging (Albany NY). 2018. PMID: 30383539 Free PMC article.
-
Early Onset of Sex-Dependent Mitochondrial Deficits in the Cortex of 3xTg Alzheimer's Mice.Cells. 2020 Jun 24;9(6):1541. doi: 10.3390/cells9061541. Cells. 2020. PMID: 32599904 Free PMC article.
-
Internet Searches and Their Relationship to Cognitive Function in Older Adults: Cross-Sectional Analysis.J Med Internet Res. 2017 Sep 6;19(9):e307. doi: 10.2196/jmir.7671. J Med Internet Res. 2017. PMID: 28877864 Free PMC article.
-
Polyphenols journey through blood-brain barrier towards neuronal protection.Sci Rep. 2017 Sep 13;7(1):11456. doi: 10.1038/s41598-017-11512-6. Sci Rep. 2017. PMID: 28904352 Free PMC article.
-
Sleep, brain vascular health and ageing.Geroscience. 2020 Oct;42(5):1257-1283. doi: 10.1007/s11357-020-00235-8. Epub 2020 Aug 3. Geroscience. 2020. PMID: 32748314 Free PMC article. Review.
References
-
- Doody RS, Thomas RG, Farlow M, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med. 2014;370:311–321. doi:10.1056/NEJMoa1312889 - PubMed
-
- Galasko DR, Graff-Radford N, May S, et al. Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals. Alzheimer Dis Assoc Disord. 2007;21:292–299. - PubMed
-
- Siemers ER, Sundell KL, Carlson C, et al. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer’s disease patients. Alzheimers Dement. 2015. doi:10.1016/j.jalz.2015.06.1893 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials